The ablation devices market is anticipated to reach more than US$ 4.4 billion in 2023. By 2033, the market is anticipated to have grown by a healthy 11.1% CAGR to reach US$ 12.6 billion. Ablation devices have emerged as a cutting-edge technology in the field of medical procedures, offering minimally invasive alternatives to traditional surgical …
Category Archives: Healthcare Trends
Dosimetry Market on Track to Attain US$ 4.3 Billion Valuation by 2029
According to a recent Future Market Insights (FMI) report, growing dosimetry market adoption at various healthcare facilities will cause market revenues to surpass US$ 4.3 billion by 2029. Strict government regulations regarding radiation toxicity levels, growing awareness about the harmful effect of radiation, and rising concerns about the health of employees working in environments with …
Continue reading “Dosimetry Market on Track to Attain US$ 4.3 Billion Valuation by 2029”
Lung Cancer Surgery Market Surges, Approaching a Valuation of US$ 1.98 Billion by 2029
The global lung cancer surgery market was estimated to be worth US$ 1.23 billion in 2021 and is projected to increase to US$ 1.98 billion by 2029, according to a recent market study by Future Market Insights (FMI). Robotic thoracic surgery would continue to be preferred over traditional surgical techniques because it provides greater magnification, …
Robotic Systems Market Combining Precision and Automation to Approach US$ 112.5 Million by 2029
The robotic catheterization systems market is anticipated to reach US$ 42.9 million in 2022 and expand at a 14.8% CAGR through 2029. Percutaneous Coronary Intervention applications will make up about 73.9% of the market for robotic catheterization systems globally in 2021, predicts Future Market Insights. Interventional and surgical robotic systems have already made a significant …
Empathy and Economics Collide: Pet Cancer Therapeutics Market to Reach US$ 1052.80 Billion by 2033
The Pet Cancer Therapeutics Market refers to the pharmaceuticals and treatment options available for pets diagnosed with cancer. It encompasses a range of therapies, including chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions, among others. The market for pet cancer therapeutics has been growing in recent years due to several factors. Firstly, there has …
Triptorelin Market Riding High On Wave of Endocrine Disorder Epidemic, Forecast To Grow At 5% CAGR Through 2033
In 2023, it is anticipated that the Triptorelin Market will be worth roughly US$ 955.50 million. From 2023 to 2033, the industry is expected to grow at a 5% CAGR, driven by the increased prevalence of endometriosis among females around the world. The triptorelin market is anticipated to produce US$ 1556.41 million by 2033. Salivary …
Hyperinsulinemia Hypoglycaemia Treatment Market is anticipated to reach US$ 179.08 Million by 2033, growing at a CAGR of 6% from 2023 to 2033
According to FMI, the Hyperinsulinemia Hypoglycaemia Treatment Market is foreseen to rise to US$ 100 million in FY 2023, representing a Y-o-Y increase of over 4%. Across the forecast period ranging from 2023 to 2033, the industry is likely to gain traction at a CAGR of 6%, reaching a market value of US$ 179.08 million …
Predictive Disease Analytics Market: Empowering Healthcare Providers to Revolutionize Patient Care With 22.5% CAGR Growth | FMI
The global Predictive Disease Analytics Market is predicted to register a CAGR of 22.5% over the forecast period, as per FMI’s analysis. The industry’s size is anticipated to increase from US$ 2.45 billion in 2023 to US$ 18.64 billion by 2033 end. The demand for predictive disease analytics is expected to increase owing to the …
Growing Prevalence Of Neurological And Chronic Pain Conditions Fueling Demand For Gabapentin Market To US$ 3.54 Billion By 2033 | FMI
The Gabapentin Market is capturing a valuation of US$ 2.11 billion in 2023 and is predicted to reach US$ 3.54 billion by 2033. The market is registering a CAGR of 5.3% during the forecast period. The Gabapentin market has witnessed significant growth in recent years, driven by its expanding range of medical applications and increasing recognition as …
Vitamin D Testing Market to Witness Luminous Growth in the Coming Decade, Reaching US$ 1,999.35 Million By 2033, Propelled By 8.1% CAGR
The Vitamin D Testing Market refers to the industry involved in the development, manufacturing, and distribution of tests used to measure the levels of vitamin D in the human body. Vitamin D is an essential nutrient that plays a crucial role in bone health, immune function, and various other physiological processes. Vitamin D testing is …